Atlas Trials

Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen

Clinical trial NCT01849497 · COMPLETED

Trial details

NCT number
NCT01849497
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary HypercholesterolemiaMixed Dyslipidemia
Start date
2013-04-18
Primary completion
2013-09-02
Enrollment
149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.